The global trial is a Phase 1b/2a trial investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of the doses of UBT251 for up to 28 weeks in about 330 people who are overweight or obese
This could result in nausea and breast tenderness
Additionally, its anti-inflammatory properties might help reduce scalp irritation and inflammation that could otherwise impair healthy hair growth
Saris D, Price A, Widuchowski W et al
Emerging research highlights the connection between weight management, hormones like Glucagon-like peptide-1 (GLP-1), and improved health, vitality, and appearance
Caring for patients with chronic diseases will require a multi-pronged approach to ensure improved health outcomes